Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Second Malignant Neoplasm
38%
Relapsed/refractory Acute Myeloid Leukemia
38%
Pediatric Leukemia
28%
T-cell Acute Lymphoblastic Leukemia (T-ALL)
26%
Acute Lymphoblastic Leukemia
24%
Unrelated Cord Blood Transplantation
21%
Pediatric Patients
21%
After childhood
21%
Cancer Genes
21%
In Cancer
21%
Relapsed/refractory
20%
Hematopoietic Stem Cell Transplantation
19%
Prognostic Factors
19%
UDP-glucuronosyltransferase
19%
NUDT15
19%
Second Malignancy
19%
Allogeneic Transplantation
19%
Pediatric Cancer
19%
Polypeptide
19%
Childhood Acute Lymphoblastic Leukemia
19%
High Incidence
19%
Global Initiatives
19%
Sigma-1 Receptor
19%
Immunoglobulin-like
19%
Pathogenic Variants
19%
Revised International Prognostic Scoring System
19%
European Medicines Agency
19%
Novel Therapies
19%
Pediatric Indication
19%
Insertion/deletion Polymorphism
19%
Natural Killer Cells
19%
Medical Devices
19%
Hypodiploid
19%
Small Molecule Inhibitors
19%
Comprehensive Genomic Profiling
19%
Pediatric T-cell Acute Lymphoblastic Leukemia
19%
Unmet Medical Need
19%
Childhood Solid Cancer
19%
Second Cancer
19%
Pharmaceutical Device
19%
Leukemia-free Survival
15%
6-mercaptopurine (6-MP)
14%
Pediatric Labeling
12%
Acute Myeloid Leukemia
11%
Lymphoblastic Malignancies
11%
Refractory Disease
9%
Host-versus-graft Direction
8%
Oncology
8%
Leukemia
7%
DICER1
7%
Biochemistry, Genetics and Molecular Biology
Pediatrics
100%
Precursor
38%
B Cell
38%
Chromosome
38%
Prevalence
25%
Germline
22%
Germ Cell
22%
Glucuronosyltransferase
19%
Disease Free Survival
19%
Platelet Derived Growth Factor Receptor Beta
19%
Kinase
19%
Phosphotransferase
19%
Mercaptopurine
19%
Genetics
17%
Janus Kinase
12%
Tyrosine Kinase Inhibitor
12%
CRLF2
12%
TCF3
9%
RUNX1
9%
ETV6
9%
PBX1
9%
Overall Survival
9%
Survival Rate
9%
Genetic Variation
7%
Genetic Divergence
7%
Exome Sequencing
7%
Cytogenetics
7%
Last Year Needle
6%
Event Free Survival
6%
Tyrosine Kinase Receptor
6%
Cytokine Receptor
6%
IKZF1
6%
Allogeneic Hematopoietic Stem Cell Transplantation
6%
Leukocyte Count
6%
Gene Expression Profiling
6%
Hematopoietic Stem Cell Transplantation
5%
Medicine and Dentistry
Acute Myeloid Leukemia
38%
Pediatrics Patient
33%
Pediatrics
26%
Acute Leukemia
26%
Diseases
24%
Malignant Neoplasm
21%
Leukemia in Children
19%
International Prognostic Scoring System
19%
MEK Inhibitor
19%
Histiocytic Sarcoma
19%
Trametinib
19%
Posttraumatic Growth
19%
Myelodysplastic Syndrome
19%
Hematopoietic Stem Cell Transplantation
19%
Pediatric Myelodysplastic Syndrome
19%
Aprepitant
19%
Fosaprepitant
19%
Overall Survival
11%
Neoplasm
11%
Hazard Ratio
9%
Pediatric Acute Myeloid Leukemia
8%
Stem Cell
7%
Chemotherapy
7%
Leukemia
5%